Published in Neurology on March 28, 2000
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain (2011) 1.61
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood (2009) 1.59
The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol (2001) 1.56
Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. Proc Natl Acad Sci U S A (2005) 1.54
B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol (2011) 1.45
Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol (2005) 1.43
B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest (2012) 1.35
CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome. J Neuroimmunol (2008) 1.17
Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF. Neurology (2007) 1.12
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroimmunol (2010) 0.99
B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv Immunol (2008) 0.98
B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev (2007) 0.90
Viruses and multiple sclerosis. Neuroscientist (2011) 0.90
B cells in multiple sclerosis. Front Biosci (2004) 0.86
B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells. J Autoimmun (2010) 0.84
Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders. Interdiscip Perspect Infect Dis (2010) 0.83
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function. Sci Rep (2012) 0.81
Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets. Eur Neurol (2015) 0.80
The Ins and Outs of B Cells in Multiple Sclerosis. Front Immunol (2015) 0.78
Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins. Front Immunol (2015) 0.77
MS: the return of the B cell. Neurology (2000) 0.77
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry (2001) 3.00
A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol (1998) 2.86
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology (2007) 2.76
Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology (1990) 2.75
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71
Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
The effects of torsion on the lumbar intervertebral joints: the role of torsion in the production of disc degeneration. J Bone Joint Surg Am (1970) 2.58
Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart (2008) 2.45
Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A (1981) 2.45
Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol (1996) 2.41
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Varicella-zoster virus DNA in human sensory ganglia. Nature (1984) 2.34
Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med (2001) 2.18
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology (2010) 2.01
Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol (1991) 1.91
Search for varicella zoster virus in giant cell arteritis. Ann Neurol (1998) 1.78
A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci U S A (1988) 1.74
Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer (1985) 1.71
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66
Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J Virol (1995) 1.66
The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol (2001) 1.65
Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol (1992) 1.65
Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology (1984) 1.64
Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol (1998) 1.59
Extraction of cell-associated varicella-zoster virus DNA with triton X-100-NaCl. J Virol Methods (1982) 1.58
The use of dexamethasone in women with preterm premature rupture of membranes--a multicentre, double-blind, placebo-controlled, randomised trial. Dexiprom Study Group. S Afr Med J (1999) 1.53
Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia. J Infect Dis (1992) 1.52
Varicella-zoster virus infection of human mononuclear cells. Virus Res (1987) 1.46
Structure of a new nervous system glycoprotein, Nr-CAM, and its relationship to subgroups of neural cell adhesion molecules. J Cell Biol (1991) 1.45
Hypofibrinolytic and atherogenic risk factors for stroke. J Lab Clin Med (1995) 1.42
VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41
Pre-eclampsia and maternal mortality--a universal problem. S Afr Med J (1996) 1.39
The oxygen consumption/oxygen delivery curve in severe preeclampsia: evidence for a fixed oxygen extraction state. Am J Obstet Gynecol (1993) 1.39
Amino-acid and cDNA nucleotide sequences of human Clara cell 10 kDa protein. Biochim Biophys Acta (1988) 1.39
Statement on withholding and withdrawing life-sustaining therapy. S Afr Med J (1994) 1.38
Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol (1984) 1.38
The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol (1995) 1.36
Isolation of Herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet (1977) 1.30
Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain. J Neuroimmunol (1999) 1.28
Idiopathic familial myocardiopathy in three generations: a clinical and pathologic study. Am Heart J (1978) 1.26
Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J Virol (1999) 1.25
Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol (1996) 1.25
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol (1973) 1.21
Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A (2001) 1.19
Zoster myelitis: improvement with antiviral therapy in two cases. Neurology (1996) 1.19
Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol (1995) 1.18
Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies. Lab Invest (1977) 1.18
Men who have sex with men and women in Bangalore, South India, and potential impact on the HIV epidemic. Sex Transm Infect (2010) 1.16
Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler (2004) 1.15
Aeromonas hydrophila infections following use of medicinal leeches in replantation and flap surgery. Ann Plast Surg (1992) 1.15
The patterns of varicella zoster virus encephalitis. Hum Pathol (1996) 1.15
Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia. Proc Natl Acad Sci U S A (1988) 1.14
Configuration of latent varicella-zoster virus DNA. J Virol (1995) 1.12
The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab Anim Sci (1986) 1.12
Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF. Neurology (2007) 1.12
Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis (1992) 1.12
A randomised controlled trial of intravenous magnesium sulphate versus placebo. Br J Obstet Gynaecol (1998) 1.10
Brain "identifier sequence" is not restricted to brain: similar abundance in nuclear RNA of other organs. Science (1985) 1.10
Developmental changes of cerebral ketone body utilization in human infants. Hoppe Seylers Z Physiol Chem (1974) 1.10
Cerebellar hypoplasia in neonatal rats caused by lymphocytic choriomeningitis virus. Science (1971) 1.09
Sexual identity and its contribution to MSM risk behavior in Bangaluru (Bangalore), India: the results of a two-stage cluster sampling survey. J LGBT Health Res (2008) 1.08
Crystal structure of ZnWO(4) scintillator material in the range of 3-1423 K. J Phys Condens Matter (2009) 1.07
Trans-activation of viral tk promoters by proteins encoded by varicella zoster virus open reading frames 61 and 62. Virus Res (1990) 1.07
Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci U S A (1988) 1.05
Resonant addressing and manipulation of silicon vacancy qubits in silicon carbide. Phys Rev Lett (2012) 1.05
Fibreoptic laryngoscopy in the assessment of laryngeal disorders. J Laryngol Otol (1975) 1.05
Simian varicella virus infects ganglia before rash in experimentally infected monkeys. Virology (2001) 1.04
The production of varicella Zoster virus antiserum in laboratory animals. Brief report. Arch Virol (1982) 1.03
Importance of spin-orbit interaction for the electron spin relaxation in organic semiconductors. Phys Rev Lett (2013) 1.02
Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia. Virology (1992) 1.02
An animal model of varicella virus infection. Brain Pathol (2001) 1.01
A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice. Arch Virol (1983) 1.01
The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes. Clin Immunol (2001) 1.01
Infectious simian varicella virus expressing the green fluorescent protein. J Neurovirol (1998) 0.99
The search for virus in multiple sclerosis brain. Mult Scler (1996) 0.98
Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features. Lab Invest (1992) 0.97
Prevalence of treated and untreated DSM-III schizophrenia. Results of a two-stage community survey. J Nerv Ment Dis (1985) 0.96
The problems of latent varicella zoster virus in human ganglia: precise cell location and viral content. J Neurovirol (1999) 0.96
Varicella-zoster virus infection of human brain cells and ganglion cells in tissue culture. Arch Virol (1978) 0.96
[Cytophotometric RNA and protein determination in the membranous labyrinth of guinea pigs as a basis for the evaluation of protein metabolism and streptomycin ototoxicity]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1969) 0.95
Factors influencing manual muscle tests in physical therapy. J Bone Joint Surg Am (1978) 0.94
Varicella-zoster virus gene 21: transcriptional start site and promoter region. J Virol (1998) 0.93
Experimental panencephalitis induced in suckling mice, by parainfluenza type 1 (6/94) virus, II. Virologic studies. J Neuropathol Exp Neurol (1976) 0.93
Profound cerebrospinal fluid pleocytosis and Froin's Syndrome secondary to widespread necrotizing vasculitis in an HIV-positive patient with varicella zoster virus encephalomyelitis. J Neurol Sci (1998) 0.92